Company Directory - 23andMe Holding Co.
Company Details - 23andMe Holding Co.
23andMe Holding Co.
WebsiteSunnyvale, United States
A biotechnology company focused on genetic testing and research.
CCI Score
CCI Score: 23andMe Holding Co.
-39.38
0.02%
Latest Event
23andMe Data Breach and Bankruptcy Raises Consumer Privacy Concerns
Following a significant data breach that compromised the genetic data of millions, 23andMe has filed for bankruptcy protection. Regulatory officials have urged consumers, especially in California, to delete their accounts due to concerns over long-term data retention practices and inadequate cybersecurity measures.
Take Action
So what can you do? It's time to make tough choices. Where will you cast your vote?
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
TOADIE
23andMe Holding Co. is currently rated as a Toadie.
Latest Events
- MAR252025
Following a significant data breach that compromised the genetic data of millions, 23andMe has filed for bankruptcy protection. Regulatory officials have urged consumers, especially in California, to delete their accounts due to concerns over long-term data retention practices and inadequate cybersecurity measures.
- MAR252025
Following its Chapter 11 bankruptcy filing, 23andMe is under scrutiny for its potential failure to safeguard sensitive genetic data. Political figures including California AG Rob Bonta and Sen. Ron Wyden have warned consumers about the risk of future data misuse if new ownership does not honor existing data protections.
- MAR252025
23andMe's chapter 11 bankruptcy filing has raised significant privacy alarms as the potential sale of millions of users' genetic data threatens consumer rights and exposes individuals to future authoritarian abuses. Critics worry that the lack of robust safeguards could enable the misuse of sensitive information, reinforcing oppressive surveillance trends.
- MAR242025
23andMe filed for Chapter 11 bankruptcy while its shares plummeted by over 50%, raising alarm over the handling of sensitive genetic data provided by over 15 million customers. The potential sale of this data amidst financial distress, coupled with a privacy warning from California Attorney General Rob Bonta, has sparked concerns about the company's ethical responsibilities and the broader implications for consumer privacy and potential misuse by authoritarian entities.
-50
Business Practices and Ethical Responsibility
March 24
23andMe’s financial collapse and bankruptcy filing put at risk a trove of sensitive genetic data from over 15 million individuals. The possibility of this data being sold or mishandled raises serious concerns about the company’s ethical responsibilities. Such a scenario could lead to abuses that may empower authoritarian regimes or undermine individual privacy rights, aligning with broader fears of corporate complicity in enabling illiberal practices.
23andMe shares tumble after bankruptcy filing and California attorney general’s privacy warning
-40
Technology and Services Impact
March 24
The handling of sensitive genetic data is a prime example of technology and service impacts on individual rights. In this case, the imminent risk of the data being commodified due to bankruptcy proceedings poses significant threats to privacy and could indirectly contribute to surveillance or profiling practices favored by authoritarian regimes. This event underscores a failure to safeguard technology assets that are integral to personal autonomy.
23andMe shares tumble after bankruptcy filing and California attorney general’s privacy warning
- MAR242025
Amid 23andMe's Chapter 11 bankruptcy filing and previous data breaches affecting millions, concerns have emerged over the company’s handling of sensitive genetic data and the potential transfer of this data to successor entities with uncertain ethical standards.
-40
Business Practices and Ethical Responsibility
March 24
The bankruptcy and earlier data breach involving 7 million customers underscore serious issues in 23andMe's business practices. Their consumer agreements, which allow the transfer of sensitive genetic data during a bankruptcy or sale, raise ethical concerns about the potential misuse of customer information.
-30
Economic and Structural Influence
March 24
The Chapter 11 restructuring highlights underlying structural vulnerabilities. The possibility that customer data may be transferred to a successor with less robust privacy protections raises alarms about potential exploitation, potentially aiding future authoritarian practices if misused.
- MAR242025
Following a 2023 data breach, a significant financial decline, and a bankruptcy filing, 23andMe faces critical questions about its handling of sensitive genetic data. The company's practices, including potential data sales amid financial distress, raise concerns about consumer privacy and the risks of enabling authoritarian misuse of personal data.
-70
Business Practices and Ethical Responsibility
March 24
23andMe's significant lapse in protecting consumers' sensitive genetic data—highlighted by a major data breach and a subsequent $30 million settlement—illustrates a deep failure in ethical responsibility. The ensuing financial collapse and bankruptcy further underscore a neglect of the obligations to safeguard user privacy, which may indirectly support authoritarian exploitation through the misuse of genetic information.
23andMe faces an uncertain future — so does your genetic data
-60
Technology and Services Impact
March 24
The technology and data management practices at 23andMe demonstrate serious vulnerabilities. The company’s ability to modify its privacy policy unilaterally and the weak regulatory oversight leave consumers' genetic data exposed, potentially enabling its misuse in ways that could empower authoritarian tools of surveillance and control.
23andMe faces an uncertain future — so does your genetic data
-30
Public and Political Behavior
March 24
There is a broader political risk associated with 23andMe’s handling of genetic data. The potential sale of sensitive information during bankruptcy proceedings could facilitate surveillance or discriminatory practices by authoritarian regimes. This links a private business failure to wider political implications.
23andMe faces an uncertain future — so does your genetic data
-50
Economic and Structural Influence
March 24
The bankruptcy filing and the planned sale of company assets, including vast repositories of genetic data, amplify concerns over economic practices. The court-supervised sale raises the risk that sensitive consumer data may ultimately end up in the hands of entities that do not uphold robust privacy safeguards, which is problematic in the context of potential authoritarian misuse.
23andMe faces an uncertain future — so does your genetic data
- MAR242025
Amid bankruptcy proceedings, 23andMe faces scrutiny over the handling of customer genetic data. Despite assurances that data will remain secure, the potential for data to be transferred or sold raises ethical questions about consumer protection and undermines trust, particularly under conditions that may favor authoritarian exploitation.
-40
Business Practices and Ethical Responsibility
March 24
The bankruptcy filing and planned sale process expose customers to significant risks regarding their sensitive genetic information. The company’s business practices—in particular, retaining and transferring consumer data during financial distress—raise ethical concerns that may facilitate exploitation by parties with authoritarian inclinations. This lack of robust consumer data protection undermines trust and highlights poor ethical responsibility.
-15
Technology and Services Impact
March 24
The situation has raised technical concerns about the safeguarding of sensitive genetic data. With bankruptcy proceedings potentially leading to data exposure or suboptimal security measures, the event reflects poorly on the company’s ability to protect user information, increasing the risk of misuse and erosion of digital rights.
- MAR242025
Following its bankruptcy filing, 23andMe faces serious scrutiny over its handling of sensitive genetic data. The California Attorney General has urged users to delete their data, raising questions about the company's commitment to ethical business practices and consumer data protection during financial distress.
-50
Business Practices and Ethical Responsibility
March 24
23andMe's bankruptcy filing and the associated government directive for users to delete their genetic data expose shortcomings in its ethical business practices and data protection commitments. This event indicates a neglect in safeguarding sensitive consumer information at a critical financial juncture, potentially undermining public trust and fueling broader concerns about corporate responsibility in a vulnerable period.
23andMe users urged to delete their data as company files for bankruptcy
- MAR202025
Amid financial distress and potential bankruptcy, 23andMe’s handling of sensitive genetic data poses significant privacy risks for consumers, highlighting questionable business practices and technological safeguards that may expose personal information to misuse.
-40
Business Practices and Ethical Responsibility
March 24
23andMe’s consumer agreements permit the transfer or sale of sensitive genetic data in bankruptcy scenarios without robust consumer protections. This practice reflects a deficiency in ethical business practices, leaving millions at risk of having their data mishandled or exploited, especially in a regulatory environment increasingly vulnerable to authoritarian misuse.
What happens to your data if 23andMe collapses? — Harvard Gazette
-20
Technology and Services Impact
March 24
The company’s history of a major 2023 data breach combined with concerns over insufficient technological safeguards in the context of potential bankruptcy underscores a weak commitment to protecting consumer data. These lapses in technological responsibility could facilitate unauthorized data access and re-identification, potentially feeding into systems of repression if misused.
What happens to your data if 23andMe collapses? — Harvard Gazette
- SEP252024
Amid financial distress and bankruptcy protection, 23andMe's recent history of a significant data breach, board resignation, and uncertainty over the future of sensitive genetic data raises serious concerns regarding ethical practices and the management of customer information. The company's partnerships, particularly with major pharmaceutical entities, further complicate its responsibility towards safeguarding genetic data in light of potential misuse.
-40
Business Practices and Ethical Responsibility
March 24
23andMe’s handling of sensitive genetic information has come under scrutiny following a major data breach and the resignation of its board of directors. The lack of clear plans for safeguarding customer data, combined with opaque partnerships with large pharmaceutical companies, reflects poor business practices and ethical responsibility. These issues threaten customer trust and pose wider risks if the data is mismanaged or falls into the wrong hands.
-20
Technology and Services Impact
March 24
The potential mishandling and uncertain fate of sensitive genetic data, particularly as the company faces financial collapse, raises significant concerns about the impact of its technological services. The lack of robust safeguards may lead to misuse of personal genetic data, thereby indirectly enabling practices that could be exploited in authoritarian or discriminatory ways.
- SEP132024
23andMe reached a $30 million settlement over a data breach that compromised the sensitive genetic and personal data of 6.9 million customers, including individuals of Chinese and Ashkenazi Jewish ancestry. The incident highlights a significant failure in cybersecurity and ethical business practices, potentially enabling abuses that authoritarian regimes could exploit.
-40
Business Practices and Ethical Responsibility
March 24
23andMe's inability to secure sensitive customer genetic and personal data, as evidenced by the need to settle a $30 million lawsuit, demonstrates a serious lapse in business practices and ethical responsibility. The failure to alert specific vulnerable demographic groups worsen the impact, and such negligence not only harms individual privacy rights but also risks that the exposed data could be exploited in support of authoritarian agendas.
Genetic testing firm 23andMe settles data breach lawsuit for $30 million
-35
Technology and Services Impact
March 24
The data breach at 23andMe underscores significant shortcomings in the company’s cybersecurity measures. The technological failure not only jeopardizes the privacy of genetic data but also increases the risk that this sensitive information could be misused by authoritarian regimes for surveillance or discriminatory targeting.
Genetic testing firm 23andMe settles data breach lawsuit for $30 million
Alternatives
Bethesda, United States
-11.29
Sunnyvale, United States
-44.83
Boston, United States
39.22
Mountain View, United States
-8.68
Corporation
54.23
Corporation
10.44
Corporation
0.00
Corporation
0.00
Corporation
-44.70
Corporation
25.38
Industries
- 541611
- Administrative Management and General Management Consulting Services
- 541720
- Research and Development in the Social Sciences and Humanities
- 621511
- Medical Laboratories
- 541712
- Research and Development in the Physical, Engineering, and Life Sciences (Biotechnology)
- 541711
- Research and Development in Biotechnology